"A lot of the medicines we currently have are difficult for people to take, " Underberg says.

FORBES: For Merck, A New Worry Amid Success

"It's going to be a nice addition, " says James Underberg, a New York University lipidologist who participated in the Januvia trials.

FORBES: Diabetes Duel

James Underberg, an NYU cardiologist, complains that drug safety experts are too eager to use studies to answer questions they were not designed to answer.

FORBES: Magazine Article

Still, James Underberg, a cardiologist at the New York University Medical School, warned that "doctors have to be very careful not to overreact" to this kind of statistical data until statisticians have combed the data.

FORBES: Magazine Article

Underberg does not work with Glaxo.

FORBES: Magazine Article

James Underberg, a cardiologist at the New York University Medical Center who participated in trials of Januvia, says that the concern that the drug has been studied in only a limited number of patients is real, and that doctors should be cautious with new drugs.

FORBES: Magazine Article